Spironolactone Tablet, Coated
Product Images NDC 50090-6539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 50090-6539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A survival probability plot comparing Spironolactone and Placebo groups over 42 months. The y-axis shows probability from 0 to 1, and the x-axis shows time in months. Two curves represent Spironolactone (dashed line, n=822) and Placebo (solid line, n=841), with a significant difference indicated (Log-rank p < 0.001).*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A subgroup analysis forest plot showing hazard ratios (HR) and 95% confidence intervals (CI) for various patient subgroups treated with spironolactone versus placebo. The x-axis ranges from 0.2 to 1.4 indicating relative effect favoring spironolactone on the left and placebo on the right. Subgroups include age ranges, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin, ACE inhibitor (ACEI), and beta blocker use. Number of patients and percentages are listed for each subgroup. Black squares represent HR point estimates with horizontal lines for 95% CIs.*
FDA Label Image

Label Image (Lbl500906539)

Label Image (Lbl500906539)
Spironolactone 100 mg coated tablets label from A-S Medication Solutions. The label includes the NDC 50090-6539, product number 6343-0, and storage instructions to keep the product at 68 to 77 degrees Fahrenheit. The package size is 90 tablets, with each tablet containing Spironolactone USP 100 mg. The label also provides a lot number and a QR code presumably for product or safety information.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of spironolactone, showing its molecular arrangement with characteristic rings and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.